Command Palette

Search for a command to run...

Boston Bio Systems Ltd.
8.5(+3.79%)
1W: +1.74%

Boston Bio Systems Peer Comparison

Snapshot Summary

Boston Bio Systems Ltd. is significantly underperforming compared to its peers, as evidenced by its negative PE ratio, zero revenue growth, and lack of profitability metrics. Among its peers, Poly Medicure Ltd. stands out as the leader in profitability and growth, while several companies exhibit concerning financial weaknesses, such as high PE ratios without corresponding earnings.

  • Boston Bio Systems Ltd. shows no growth and poor financial metrics, placing it at a disadvantage.
  • Poly Medicure Ltd. demonstrates strong revenue growth and profitability, making it a standout performer.
  • Laxmi Dental Ltd. has a very high ROE but is also overvalued with a high PE ratio.
  • Several companies exhibit signs of financial weakness, particularly those with inflated PE ratios and low revenue growth.
  • Poly Medicure Ltd.: Highest revenue growth, strong profitability metrics, and reasonable debt levels.
  • Prevest Denpro Ltd.: Solid ROE and low debt, indicating good financial health despite lower growth.
  • Laxmi Dental Ltd.: High ROE, but high PE ratio indicates potential overvaluation.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Boston Bio Systems Ltd.₹8.91₹6.24Cr-11.39--
POLYMED₹2,072.30₹20,997.79Cr63.3720.37%0.06
LAXMIDENTL₹340.30₹1,870.36Cr100.5221.79%0.99
Prevest Denpro Ltd.₹569.55₹683.63Cr37.5625.24%-
Hemant Surgical Industries Ltd.₹297.80₹310.90Cr38.24--
NURECA₹241.55₹241.55Cr-184.25-1.06%0.00
Raaj Medisafe India Ltd.₹84.59₹111.77Cr18.23--

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.